Application of medication composition of containing oil of dalbergia wood in preparing medication for treating chronic insufficiency of supplying blood for brain

A technology of cerebral insufficiency and composition, applied in the field of medicine, can solve the problems of no focal neurological signs in the brain, and long-term efficacy that needs further research.

Inactive Publication Date: 2006-12-06
TIANJIN TASLY PHARMA CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0033] 3. No focal neurological signs of the brain
[0043] 3. No focal neurological signs of the brain;
[0044] 4. CT\MRI without vascular organic brain changes;
[0056] At present, the drugs used clinically to treat CCCI include: THA: cholinesterase inhibitor, GST-21: central N-choline receptor inhibitor, FK506: immunosuppressant, Nimsuperzine: Cox-2 inhibitor, etc. A good short-term clinical effect has been achieved, but the long-term effect needs further study

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] Take 1200g of Danshen, 1200g of Panax notoginseng, and 10.5ml of balsamic oil;

[0086] The above three flavors and Danshen were extracted twice with ethanol, each time for 70 minutes, filtered, the filtrates were combined, the ethanol was recovered and concentrated to a clear paste with a relative density of 1.20-1.25 (measured at 60°C), and set aside; Panax notoginseng was crushed into a coarse powder, 70% ethanol reflux extraction twice, each 1.5 hours, combined extracts, filtered, the filtrate reclaimed ethanol, and continued to concentrate to a clear paste with a relative density of 1.20 to 1.25 (measured at 60°C), adding a small amount of diatomaceous earth, ( 80°C) concentrated under reduced pressure to a clear paste with a relative density of 1.20-1.25 (measured at 60°C), and set aside; heat polyethylene glycol 6000 on a water bath until completely melted, add the above-mentioned salvia miltiorrhiza and Panax notoginseng extract, stir well, After cooling down sl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An application of the medical composition composed of red sage root, notoginseng and dalbergia wool oil in preparing the medicines for treating chronic cerebral ischemia is disclosed.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the application of a pharmaceutical composition containing balm oil in the preparation of medicine for treating chronic cerebral insufficiency. Background technique [0002] The origin of the concept [0003] Chronic Cerebral Circulation Inefficiency (CCCI) refers to the state of reduced blood supply to the brain at the overall level (less than 40-60ml / 100g brain tissue / minute), rather than focal cerebral ischemia. It is a relatively new disease name proposed by foreign countries in the first 10 years. Clinically, some elderly or pre-senile patients who repeatedly complain of subjective symptoms such as heavy head and dizziness have neither focal signs of nerve damage nor brain CT abnormalities except fundus arteriosclerosis. Arteriosclerosis". It is well known that the concept and clinical diagnostic criteria of cerebral arteriosclerosis have ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/537A61P9/10
Inventor 范立君郑永锋
Owner TIANJIN TASLY PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap